Search dm+d | This VMP cannot be matched against our prescribing data.
Name | Pentazocine 50mg suppositories |
BNF code | 0407020U0AAABAB |
Virtual Therapeutic Moiety | Pentazocine |
Date identifier became valid | 3 Jul 2023 |
Previous product identifier | 322604007 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Non-availability | Actual Products not Available |
Non-availability status date | 17 Feb 2005 |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | suppository |
Unit dose unit of measure | suppository |
Virtual Product Ingredient | |
---|---|
Ingredient | Pentazocine lactate |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 387213004 |
Strength value numerator | 50.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | suppository.rectal |
Dose Form | |
Formulation | Suppository |
Drug Route | |
Route | Rectal |
Controlled Drug Prescribing Information | |
Controlled Drug category | Schedule 3 (CD No Register Exempt Safe Custody) |
Date of applicability | 24 Nov 2014 |
Previous Controlled Drug information | Schedule 3 (CD No Register) |
Virtual Medicinal Product Packs | |
Pentazocine 50mg suppositories 20 suppository |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.